Similar findings have been reportedwith Chronic Lymphocytic Leukemia, as black patients present with high-riskprognostic markers, severe anemia, increase in beta-2 microglobulin levels, advancedRai staging, and cytogenetic markers associated with a worse prognosis as comparedto white patients [15,16]. The gene discussed is B2M; the disease is B-cell chronic lymphocytic leukemia.